Chan SYT - Search Results

1

Evaluation of CDK12 Protein Expression as a Potential Novel Biomarker for DNA Damage Response-Targeted Therapies in Breast Cancer.

Naidoo K, Wai PT, Maguire SL, Daley F, Haider S, Kriplani D, Campbell J, Mirza H, Grigoriadis A, Tutt A, Moseley PM, Abdel-Fatah TMA, Chan SYT, Madhusudan S, Rhaka EA, Ellis IO, Lord CJ, Yuan Y, Green AR, Natrajan R. Naidoo K, et al. Among authors: chan syt. Mol Cancer Ther. 2018 Jan;17(1):306-315. doi: 10.1158/1535-7163.MCT-17-0760. Epub 2017 Nov 13. Mol Cancer Ther. 2018. PMID: 29133620 Free PMC article.

2

C-erbB2 expression predicts response to preoperative chemotherapy for locally advanced breast cancer.

Willsher PC, Pinder SE, Gee JM, Ellis IO, Chan SY, Nicholson RI, Blamey RW, Robertson JF. Willsher PC, et al. Anticancer Res. 1998 Sep-Oct;18(5B):3695-8. Anticancer Res. 1998. PMID: 9854479

3

The role of PTEN and its signalling pathways, including AKT, in breast cancer; an assessment of relationships with other prognostic factors and with outcome.

Panigrahi AR, Pinder SE, Chan SY, Paish EC, Robertson JF, Ellis IO. Panigrahi AR, et al. J Pathol. 2004 Sep;204(1):93-100. doi: 10.1002/path.1611. J Pathol. 2004. PMID: 15307142

4

Neoadjuvant chemotherapy in locally advanced primary breast cancers: the Nottingham experience.

Mathew J, Asgeirsson KS, Agrawal A, Mukherjee A, Ellis IO, Cheung KL, Chan SY, Robertson JF. Mathew J, et al. Eur J Surg Oncol. 2007 Oct;33(8):972-6. doi: 10.1016/j.ejso.2007.02.005. Epub 2007 Mar 27. Eur J Surg Oncol. 2007. PMID: 17391905 Clinical Trial.

5

2-[(1-methylpropyl)dithio]-1H-imidazole inhibits tubulin polymerization through cysteine oxidation.

Huber K, Patel P, Zhang L, Evans H, Westwell AD, Fischer PM, Chan S, Martin S. Huber K, et al. Mol Cancer Ther. 2008 Jan;7(1):143-51. doi: 10.1158/1535-7163.MCT-07-0486. Mol Cancer Ther. 2008. PMID: 18202017

6

Growth fraction as a predictor of response to chemotherapy in node-negative breast cancer.

Aleskandarany MA, Green AR, Rakha EA, Mohammed RA, Elsheikh SE, Powe DG, Paish EC, Macmillan RD, Chan S, Ahmed SI, Ellis IO. Aleskandarany MA, et al. Int J Cancer. 2010 Apr 1;126(7):1761-9. doi: 10.1002/ijc.24860. Int J Cancer. 2010. PMID: 19711345 Free article.

7

T cell density and location can influence the prognosis of ovarian cancer.

Al-Attar A, Shehata M, Durrant L, Moseley P, Deen S, Chan S. Al-Attar A, et al. Pathol Oncol Res. 2010 Sep;16(3):361-70. doi: 10.1007/s12253-009-9230-5. Epub 2009 Dec 19. Pathol Oncol Res. 2010. PMID: 20024633 Free article.

8

Human apurinic/apyrimidinic endonuclease (APE1) is a prognostic factor in ovarian, gastro-oesophageal and pancreatico-biliary cancers.

Al-Attar A, Gossage L, Fareed KR, Shehata M, Mohammed M, Zaitoun AM, Soomro I, Lobo DN, Abbotts R, Chan S, Madhusudan S. Al-Attar A, et al. Br J Cancer. 2010 Feb 16;102(4):704-9. doi: 10.1038/sj.bjc.6605541. Epub 2010 Jan 19. Br J Cancer. 2010. PMID: 20087352 Free PMC article.

9

Topo2α protein expression predicts response to anthracycline combination neo-adjuvant chemotherapy in locally advanced primary breast cancer.

Mukherjee A, Shehata M, Moseley P, Rakha E, Ellis I, Chan S. Mukherjee A, et al. Br J Cancer. 2010 Dec 7;103(12):1794-800. doi: 10.1038/sj.bjc.6605960. Epub 2010 Nov 9. Br J Cancer. 2010. PMID: 21063406 Free PMC article.

10

Calpain-1 expression is associated with relapse-free survival in breast cancer patients treated with trastuzumab following adjuvant chemotherapy.

Storr SJ, Woolston CM, Barros FF, Green AR, Shehata M, Chan SY, Ellis IO, Martin SG. Storr SJ, et al. Int J Cancer. 2011 Oct 1;129(7):1773-80. doi: 10.1002/ijc.25832. Epub 2011 Mar 8. Int J Cancer. 2011. PMID: 21140455 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

157 results

Search Page